Mark Malesker, PharmD, discusses the clinical evidence, drug interaction risks, and formulary challenges surrounding cannabinoid use for sleep disorders.

In a review of previous studies, McMaster University researchers observe a stronger signal for psilocybin as a treatment for obsessive-compulsive disorder than cannabinoids. Obsessive-compulsive ...

When we think cannabis, most of us think of the chemical THC — although CBD is quickly rising in popularity, too. Both cannabidiol and tetrahydrocannabinol, to give them their full names, are ...

Colorectal cancer is the third leading cause of cancer mortality in the U.S. The American Cancer Society estimates that this year alone, there will be 106,180 new cases of colon cancer diagnosed. Two ...

What is the role of cannabinoids as an intoxicant and in medical applications today? This was the question addressed by Dieter Braus, MD, psychiatrist and neurologist at Vitos Clinic Rheingau in ...

Dr. Ilana Braun and Dr. Eric Roeland join us on the ASCO Guidelines podcast to discuss the latest evidence-based recommendations on cannabis and cannabinoids in adults with cancer. They discuss ...

Research from pharmacologists at the University of Sydney provides new insights into how cannabis extracts may work to treat epilepsy. The study for the first time reports that three acidic ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. THC and CBD are the two most common cannabinoids, or chemical compounds, found in cannabis. But there ...

Kentucky has demonstrated leadership in responsible hemp oversight. But unnecessary changes in Washington have put that ...